Description
ViperaTAb™, a Polyvalent Immune Fab (Ovine), comprises specific antibody fragments that bind and neutralise Vipera berus venom components, including proteases, lipases and cardiotoxins, facilitating their redistribution away from target tissues and subsequent elimination from the body.

Further Information
ViperaTAb™ is an antidote for the treatment of snakebites from the European common adder (Vipera berus), offering a treatment for the 750 bites which occur each year in the Europe*. This product is currently being sold on a named patient basis in Scandinavia and Germany under an agreement with Swedish Orphan International AB, and in the rest of Europe by BTG.

*BTG estimates; based on Reading, CJ (1996) Incidence, pathology and treatment of adder (Vipera berus L) bites in man. Journal of Accident and Emergency Medicine, 13, 346-351

Full Prescribing Information for Medical Professionals
Product Supplies

Return to Marketed Products